This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
milla1cf Sun, 04/07/2024 - 18:09 April 7, 2024 — Among patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to standard cholesterol-lowering medication for one year reduced LDL, or “bad” cholesterol, levels by more than half on average, compared with a placebo.
After treatment, three-months major adverse cardiovascular events (MACE) were assessed as the primary outcome. This therapeutic effect is likely due to the active components of FFDS targeting key proteins: LPL, CD36, FABPpm, L-FABP, LCAT, and CEPT.Clinical Trial Registration[link] identifier (ChiCTR2400080149).
The (+) and () signs mean that the variable has a positive or a negative association with growth differentiation factor-15 (GDF-15) levels in the fully adjusted model (age, gender, current smoker, body mass index, total cholesterol, systolic blood pressure and N-terminal pro-B-type natriuretic peptide), respectively.
Circulation, Ahead of Print. BACKGROUND:Cholesterol efflux capacity (CEC) predicts cardiovascular disease independently of high-density lipoprotein (HDL) cholesterol levels. Despite their very low plasma levels of HDL particles, these subjects had normal CEC.
Lowering low‐density lipoprotein cholesterol (LDL‐C) is a cornerstone of reducing risk for atherosclerotic cardiovascular disease. Twice‐yearly maintenance subcutaneous inclisiran (following initial loading doses at Day 1 and Day 90) reduces circulating LDL‐C levels by ≈50% versus placebo when added to maximally tolerated statins.
Researchers have identified a new pathway that contributes to cardiovascular disease associated with high levels of niacin, a common B vitamin previously recommended to lower cholesterol. The team discovered a link between 4PY, a breakdown product from excess niacin, and heart disease.
Circulation, Volume 150, Issue 9 , Page 724-735, August 27, 2024. Familial hypercholesterolemia (FH) is a genetic disease that leads to elevated low-density lipoprotein cholesterol levels and risk of coronary heart disease. DNA- and RNA-based therapeutics have the potential to transform the care of patients with FH.
Nature Reviews Cardiology, Published online: 28 March 2024; doi:10.1038/s41569-024-01021-1 A new study identifies a hormone that is secreted by the gut in response to cholesterol absorption and can inhibit cholesterol synthesis in the liver, which prevents an increase in circulatingcholesterol levels.
Labelling of cholesterol as Good and bad , are immature scientific conclusions. Can any one believe this as truth, that there is little correlation between circulating blood lipids with arterial plaque lipids ? Remember , there is no intravascular war going on between good and bad cholesterol. Final message.
Modified low-density lipoproteins (LDL), such as oxidized LDL (oxLDL), small dense LDL (sdLDL), and electronegative LDL [LDL(-)], are capable of triggering the atherogenic process, favoring the subendothelial accumulation of cholesterol and promoting inflammatory, proliferative, and apoptotic processes characteristic of atherosclerotic lesions.
Circulation: Cardiovascular Imaging, Volume 16, Issue 11 , Page e015589, November 1, 2023. BACKGROUND:Recent studies have shown that remnant cholesterol (RC) is associated with incident heart failure; however, its association with left ventricular (LV) structure and function is unclear.
PAD is a serious condition affecting circulation and blood vessels, causing them to narrow from plaque buildup in the arteries and blocking blood flow to the extremities, typically the legs and feet. It is triggered by atherosclerosis, which occurs when fatty deposits or cholesterol accumulates… Source
Circulation, Volume 150, Issue Suppl_1 , Page A4125511-A4125511, November 12, 2024. Background:Serum lipids and ratios are known to be associated with cardiovascular disease (CVD). However, studies on NHHR and the association with arterial stiffness in the US population have not been reported.
I do apologise for being direct, but this issue is one of the most frequent barriers I encounter to initiating cholesterol-lowering therapy. At the exact same time, cholesterol concentrations are also at their lowest. At the exact same time, cholesterol concentrations are also at their lowest. Let’s break this down.
The fundamental characteristic of atherosclerosis is when a cholesterol particle becomes trapped in the artery wall. Each of these particles contains varying amounts of LDL cholesterol (CE) and triglycerides INSIDE the particle. CE = Cholesterol Ester. Share But what about LDL cholesterol? TG = Triglycerides.
Circulation: Cardiovascular Imaging, Ahead of Print. P<0.001), and cholesterol crystal (42.0% BACKGROUND:Recently, it was reported that noncalcified plaque (NCP) volume was an independent predictor for cardiac events. versus 75.9%;P<0.001), P<0.001), thin-cap fibroatheroma (38.1% versus 20.7%;P<0.001),
‘Normal’ levels of risk factors such as blood pressure, cholesterol or blood glucose levels are often FAR from optimal. This is why a female who develops high LDL cholesterol much later in life is at far less risk than a female who has had high LDL cholesterol ALL of her life. Circulation. J Am Coll Cardiol.
Every lipoprotein particle has one APO B protein. ( **Please note the B ) When we measure APO B levels, this is what we are measuring to give an estimate of the number of cholesterol particles and the subsequent risk of cardiovascular disease. APO E is also centrally involved in cholesterol metabolism. Here’s how. What to do?
Raised lipoprotein(a) (Lp[a]) cholesterol is highly prevalent affecting 1 in 5 individuals and is also frequently associated with the inherited condition familial hypercholesterolaemia (FH).
Factors such as smoking, high blood pressure, high cholesterol levels, obesity, and a sedentary lifestyle significantly increase the risk of developing cardiovascular disease. Engaging in activities such as running, swimming, or cycling helps strengthen the heart, increase lung capacity, and improve blood circulation.
Flow cytometry was performed to characterize baseline circulating M1- and M2-macrophages and monocytes. BackgroundSome clinical dyslipidemia cases do not respond to statins, known as statin-resistant familial hypercholesterolemia (SR-FH), in which patients are under a high cardiovascular risk despite statin therapy.
Objective The reduction in circulating low-density lipoprotein cholesterol (LDL-c) is the primary aim of lipid-lowering therapies as a method of atherosclerotic cardiovascular disease risk reduction. mmol/L and total cholesterol from 5.7±1.3 Data on adverse events were also recorded. mmol/L by 48.6% mmol/L by 33.3%
Circulation, Volume 150, Issue Suppl_1 , Page A4147134-A4147134, November 12, 2024. Introduction:Elevated LDL cholesterol is linked to microvascular injury and adverse cardiac events in STEMI patients. Statins, or HMG CoA reductase inhibitors, lower LDL levels and reduce cardiovascular risk. and an odds ratio (OR) of 0.54
Addressing an Unmet Need in Pediatric Patients with HeFH Heterozygous familial hypercholesterolemia (HeFH) affects about 1 in 313 people—characterized by dangerously high low-density lipoprotein cholesterol (LDL-C) levels. Untreated, it can trigger early heart disease.
Circulation, Ahead of Print. BACKGROUND:Homozygous familial hypercholesterolemia (HoFH) is a rare genetic disorder characterized by severely elevated low-density lipoprotein cholesterol (LDL-C) levels due to profoundly defective LDLR (LDL receptor) function.
Circulation, Ahead of Print. High-cholesterol diet–fed ApoE–/–mice with AVCAPIR knockout were used to examine the role of AVCAPIR in aortic valve calcification (AVC). BACKGROUND:Calcification of the aortic valve leads to increased leaflet stiffness and consequently results in the development of calcific aortic valve disease (CAVD).
Exercise helps strengthen your heart muscle, improves circulation, and lowers blood pressure and cholesterol levels, all of which are crucial for maintaining optimal cardiac health. Schedule regular appointments with your healthcare provider to have your blood pressure, cholesterol levels, and other cardiac risk factors checked.
(Article will be linked) We know ,HDL carries free cholesterol from peripheral cells, including macrophages and endothelial cells. This is the much famous Reverse Cholesterol Transport(RCT) and the anti-atherosclerotic effect of HDL.It is expected to change its shape like a chameleon, while ferrying the cholesterol to liver.
Circulation, Volume 150, Issue Suppl_1 , Page A4143314-A4143314, November 12, 2024. As part of the program, VA sites work with an AHA QI Consultant develop and deploy a local quality improvement plan to help overcome site specific barriers preventing Veterans from achieving optimal cholesterol levels.At
Circulation, Volume 150, Issue Suppl_1 , Page A4141400-A4141400, November 12, 2024. They contain dietary triglycerides, cholesterols, and apolipoproteins. Introduction:Chylomicrons are major lipid fuel for cells. In the intestine, apolipoprotein C-III (apoC-III) is produced during fat feeding, and secreted onto chylomicrons.
Circulation, Ahead of Print. BACKGROUND:Homozygous familial hypercholesterolemia is a genetic disease characterized by extremely high levels of low-density lipoprotein cholesterol (LDL-C) and a high risk of premature cardiovascular events.
Circulation, Volume 150, Issue Suppl_1 , Page A4147625-A4147625, November 12, 2024. CMS was defined as having ≥3 of five CMS components: large waist circumference, HBP, elevated triglycerides, elevated glucose, and low HDL-cholesterol. Background:Cardiometabolic syndrome (CMS) poses a significant public health concern.
Exercise helps improve blood circulation, strengthen the heart and manage weight—all of which can help reduce the risk of PAD. A diet rich in fruits, vegetables, whole grains and lean proteins can help control blood pressure, cholesterol levels and weight. Early detection is key to effective treatment and management.
Circulation: Genomic and Precision Medicine, Volume 17, Issue 6 , Page e004674, December 1, 2024. Enrichment analyses identified patterns consistent with impaired metabolic functions, including reduced triglyceride and cholesterol handling ability. locus to these traits.
In time course experiments on C57BL/6 mice (1d, 3d and 7d post-MCAO), the same technique was performed using Staph A pHrodo bioparticles, BODIPY, LipiM and Bodipy-cholesterol probes to explore changes in neutral lipid level, lipid uptake, and phagocytic activity of leukocytes.
Circulation, Volume 150, Issue Suppl_1 , Page A4143445-A4143445, November 12, 2024. Introduction:Maintaining a heart-healthy lifestyle is crucial for good cardiovascular health. However, the moderating effects of age and gender on the relationship of diet quality, smoking status, and exercise to cardiovascular health are unknown.
Circulation, Volume 150, Issue Suppl_1 , Page A4139995-A4139995, November 12, 2024. Patients without data on C-reactive protein and high-density lipoprotein cholesterol and those who had a history of coronary artery bypass grafting and stenting in the left anterior descending artery were excluded. Recently, Rinaldi et al.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content